Molecular Diagnostics of Arthroconidial Yeasts, Frequent Pulmonary Opportunists

Journal of Clinical Microbiology
Engin KaplanG Sybren de Hoog

Abstract

Magnusiomyces capitatus and Saprochaete clavata are members of the clade of arthroconidial yeasts that represent emerging opportunistic pulmonary pathogens in immunocompromised patients. Given that standard ribosomal DNA (rDNA) identification often provides confusing results, in this study, we analyzed 34 isolates with the goal of finding new genetic markers for classification using multilocus sequencing and amplified fragment length polymorphism (AFLP). The interspecific similarity obtained using rDNA markers (the internal transcribed spacer [ITS] and large subunit regions) was in the range of 96 to 99%, whereas that obtained using protein-coding loci (Rbp2, Act, and Tef1α) was lower at 89.4 to 95.2%. Ultimately, Rbp2 was selected as the best marker for species distinction. On the basis of cloned ITS data, some strains proved to be misidentified in comparison with the identities obtained with phenotypic characters, protein sequences, and AFLP profiles, indicating that different copies of the ribosomal operon were present in a single species. Antifungal susceptibility testing revealed that voriconazole had the lowest MIC against M. capitatus, while amphotericin B had the lowest MIC against S. clavata Both species exhibited in v...Continue Reading

References

Jul 1, 1987·Journal of Clinical Microbiology·E GuéhoS A Meyer
Apr 1, 1997·International Journal of Systematic Bacteriology·H J PhaffC P Kurtzman
Dec 22, 1999·Molecular Biology and Evolution·Y J LiuB D Hall
Aug 9, 2001·International Journal of Systematic and Evolutionary Microbiology·H M DanielW Meyer
Jan 17, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Rodrigo MartinoJorge Sierra
Sep 10, 2009·Antimicrobial Agents and Chemotherapy·Paul ChittickJames E Peacock
Nov 26, 2011·Fungal Biology·Iraz AlperSteve Labrie
Jan 21, 2012·Emerging Infectious Diseases·Tanja BirrenbachStefan Zimmerli
Jun 9, 2012·IMA Fungus·David L HawksworthNing Zhang
Oct 10, 2013·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·M C ArendrupUNKNOWN European Confederation of Medical Mycology
Jan 1, 2012·Medical Mycology Case Reports·Fatma SaghrouniMoncef Ben Said
Nov 13, 2014·BMC Infectious Diseases·Abdullah M S Al-HatmiAnne D van Diepeningen
Apr 15, 2015·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Oliver A CornelyUNKNOWN EORTC Infectious Diseases Group
Oct 21, 2015·Medical Mycology·Hosuru Subramanya SupramPrasanna Honnavar
Aug 9, 2016·Medical Mycology·Mario Fernández-RuizUNKNOWN GEIH-GEMICOMED (SEIMC) and REIPI

❮ Previous
Next ❯

Citations

Dec 7, 2018·Medical Mycology·Maria Carmela EspostoAnna Maria Tortorano
Nov 21, 2018·Current Genetics·Bronislava BrejováJozef Nosek
Nov 19, 2019·Frontiers in Microbiology·Vladimir BuchtaPavel Žák
Jul 26, 2018·Life·Alessia MarchettaFilomena De Leo

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Aspergillosis

Aspergillosis is the name given to a wide variety of diseases caused by infection by fungi of the genus Aspergillus. Aspergillosis occurs in chronic or acute forms which are clinically very distinct. Most cases of acute aspergillosis occur in patients with severely compromised immune systems. Chronic colonization or infection can cause complications in people with underlying respiratory illnesses. Discover the latest research on aspergillosis here.

Aspergillosis (ASM)

Aspergillosis is the name given to a wide variety of diseases caused by infection by fungi of the genus Aspergillus. Aspergillosis occurs in chronic or acute forms which are clinically very distinct. Most cases of acute aspergillosis occur in patients with severely compromised immune systems. Chronic colonization or infection can cause complications in people with underlying respiratory illnesses. Discover the latest research on aspergillosis here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.